
Journal of Medicinal Chemistry p. 1364 - 1368 (1993)
Update date:2022-09-26
Topics:
Florent, Jean-Claude
Gaudel, Gilbert
Monneret, Claude
Hoffmann, Dieter
Kraemer, Hans-Peter
The synthesis and biological activity of the new 4-demethoxyanthracyclines 15, 22, and 23 are reported.They were obtained from synthetic 9-deacetyl-9-(hydroxymethyl)-4-demethoxydaunomycinone (isopropylidene derivative 9) and from 4-azido- or 4-amino-2,4,6-trideoxy-L-lyxo-hexoses.Anthracycline 22 (hydrochloride salt), the most active compound in the series, was slightly more potent than doxorubicin in vitro against three cell lines (L1210, HT29, A549).It was found to exhibit similar antitumor activity in vivo (iv route) against L1210 leukemia, but was less activethan doxorubicin against three human tumors in a subrenal capsule assay (LX, A549, and HT29).
View Morewebsite:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Chengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Contact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
Doi:10.1016/j.jfluchem.2011.06.031
(2011)Doi:10.1055/s-1996-4196
(1996)Doi:10.1016/j.tetlet.2011.08.130
(2011)Doi:10.1021/jo00014a032
(1991)Doi:10.1039/c4ra07983c
(2014)Doi:10.1021/ic200872a
(2011)